Baclofen
Is It Right for You?
A complete guide to Baclofen — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Baclofen?
Baclofen is a centrally acting skeletal muscle relaxant and antispastic agent, classified pharmacologically as a GABA-B receptor agonist. It acts on inhibitory pathways in the spinal cord to reduce the excessive muscle contraction (spasticity), painful spasms, and clonus that characterise upper motor neuron lesions — most commonly multiple sclerosis, spinal cord injury or disease, cerebral palsy, stroke, and traumatic brain injury.
Baclofen is available in the UK as oral tablets (10 mg) and as an oral liquid (5 mg/5 mL), allowing flexible dose titration. In carefully selected patients with severe spasticity unresponsive to oral therapy, baclofen can also be delivered directly into the cerebrospinal fluid via an implanted intrathecal pump — a specialist procedure performed in neurology or neurosurgery centres.
Oral baclofen is typically introduced at a low dose (5 mg three times daily) and gradually titrated upward every few days to balance therapeutic benefit against side effects (most commonly drowsiness, dizziness, and muscle weakness). Typical maintenance doses range from 30 to 75 mg per day in divided doses, with a maximum of 100 mg per day in most patients.
Baclofen is a prescription-only medication in the UK and is usually initiated and supervised by a specialist clinician (neurologist, rehabilitation medicine specialist, or GP with specialist input). It is one of the most established first-line oral agents for the management of spasticity and is on the WHO List of Essential Medicines.
What Conditions Is Baclofen Used For?
Baclofen is prescribed for the management of spasticity and associated symptoms in:
Baclofen is licensed for the management of muscle spasticity arising from multiple sclerosis (MS) — including flexor and extensor spasms, painful muscle cramps, clonus, and rigidity. It is one of the most established first-line oral antispastic agents for MS-related spasticity and can substantially improve mobility, comfort, and quality of life.
Baclofen is used to manage spasticity arising from spinal cord injury, transverse myelitis, syringomyelia, and other diseases or trauma affecting the spinal cord. By reducing the spinal excitatory drive that produces muscle hyperactivity, it helps with pain, sleep, hygiene, and physical rehabilitation.
Baclofen is widely used for spasticity caused by cerebral injury — including stroke, traumatic brain injury, and cerebral palsy in older children and adults — where increased muscle tone interferes with positioning, mobility, function, and care. Use in cerebral palsy is typically under specialist supervision.
Baclofen relieves the painful muscle spasms, clonus, and cramps that accompany spasticity in many neurological conditions. By reducing the intensity and frequency of involuntary contractions, it improves pain, sleep quality, and tolerance of physiotherapy and stretching programmes.
Used off-label in some patients for intractable hiccup, particularly in palliative care, and for selected cases of trigeminal neuralgia where first-line agents (carbamazepine) have been ineffective or are not tolerated. These uses are specialist-initiated.
Baclofen reduces muscle tone, spasm, and clonus arising from upper motor neuron lesions — but it does not treat the underlying neurological condition itself. Optimal management of spasticity combines pharmacological treatment with physiotherapy, stretching programmes, postural management, occupational therapy, and (in selected cases) specialist interventions such as botulinum toxin injection or intrathecal baclofen.
How Does Baclofen Work?
Baclofen is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), specifically targeting GABA-B receptors in the central nervous system. Unlike GABA itself, baclofen crosses the blood-brain barrier in clinically useful amounts, allowing oral dosing to produce central effects.
GABA-B receptor agonism in the spinal cord: Baclofen's principal action is as a selective agonist at GABA-B receptors located on presynaptic and postsynaptic terminals within the spinal cord, particularly in the substantia gelatinosa and around motor neuron pools. Presynaptic GABA-B activation reduces the release of excitatory neurotransmitters (notably glutamate and substance P) from primary afferent neurons. Postsynaptic GABA-B activation produces neuronal hyperpolarisation through opening of potassium channels and inhibition of voltage-gated calcium channels. The combined effect is suppression of both monosynaptic and polysynaptic reflexes in the spinal cord — the pathways responsible for spasticity, clonus, and painful flexor and extensor spasms.
Reduction in muscle tone and spasm: By dampening the spinal excitatory drive that produces involuntary muscle contraction, baclofen reduces muscle tone, decreases the frequency and severity of spasms, lessens clonus, and improves passive range of motion. Crucially, it does not act directly on muscle fibres or at the neuromuscular junction, so it does not cause the kind of generalised peripheral muscle weakness associated with neuromuscular blockers — although some functional weakness can occur with higher doses or over-suppression of tone.
Pharmacokinetics: Baclofen is rapidly absorbed after oral administration with bioavailability around 70‐85%. It is excreted primarily unchanged in the urine, with a half-life of 3–4 hours. Renal excretion means that dose reduction is essential in patients with impaired renal function to avoid accumulation, severe sedation, and toxicity.
Intrathecal delivery for severe cases: In patients with severe spasticity inadequately controlled by oral baclofen, the same drug can be delivered directly into the cerebrospinal fluid via an implanted intrathecal pump. This achieves much higher local concentrations at the spinal cord with far lower systemic exposure, but is reserved for specialist neurological centres.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Take baclofen with or after food to reduce the risk of nausea and gastrointestinal upset.
Start at a low dose and increase gradually as directed by your clinician, typically by 5 mg every 3 days. Gradual titration significantly reduces drowsiness and dizziness at initiation.
Take doses spread evenly through the day (typically three or four times daily) to provide consistent symptom control. Build doses into a fixed routine to help with adherence.
Do not drive or operate machinery until you know how baclofen affects you — particularly during the first few weeks and after any dose increase. Avoid alcohol and other sedating medication.
Never stop baclofen suddenly after extended use. Withdrawal must always be tapered gradually over at least 1–2 weeks under clinical supervision, because abrupt discontinuation can cause seizures, hallucinations, and severe rebound spasticity.
If you miss several consecutive doses, contact your clinician for advice rather than restarting at your usual dose, because of the risk of withdrawal symptoms after even short interruptions of long-term treatment.
Attend regular reviews with your clinician. Baclofen should be assessed for ongoing benefit, side effects, and renal function (which affects clearance) at least every 6–12 months.
Side Effects of Baclofen
The most common side effects are dose-related and largely reduced by gradual titration. Serious side effects are uncommon at standard doses but require immediate medical attention.
- Drowsiness and sedation — very common, particularly at initiation or after dose increases
- Dizziness and unsteadiness
- Muscle weakness
- Nausea, vomiting, or constipation
- Dry mouth
- Headache
- Confusion (more common in elderly)
- Insomnia or vivid dreams
- Mild hypotension
- Severe withdrawal syndrome with abrupt discontinuation — seizures, hallucinations, confusion, hyperthermia, severe rebound spasticity, rhabdomyolysis; can be fatal; tapering is essential
- Respiratory depression — particularly at higher doses, in overdose, with renal impairment, or when combined with CNS depressants
- Severe sedation, coma, and overdose toxicity — baclofen overdose can be life-threatening, particularly in renal impairment
- Seizures — baclofen can lower the seizure threshold, particularly during withdrawal or at high doses
- Severe muscle weakness — may compromise mobility and posture in patients who rely on residual tone
- Hallucinations, confusion, and psychiatric disturbance — particularly in elderly patients and at higher doses
- Severe hypotension — dizziness on standing, falls; particularly in combination with antihypertensives
- Hepatic dysfunction — rare; raised liver enzymes occasionally reported
- Urinary retention — particularly in patients with bladder dysfunction
The most clinically important safety issue with baclofen is the severe withdrawal syndrome that can occur after abrupt discontinuation following long-term use. This syndrome can include seizures, hallucinations, confusion, hyperthermia, severe rebound spasticity, rhabdomyolysis, and — in rare cases — death. Patients and prescribers must be explicitly aware that baclofen must never be stopped suddenly: any dose reduction or discontinuation must be tapered gradually over at least 1–2 weeks under clinical supervision.
Drug Interactions
Baclofen interacts with a number of medications, most importantly central nervous system depressants and certain blood-pressure-lowering drugs. Always disclose all prescription medications, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting baclofen.
Alcohol, opioids, benzodiazepines, Z-drugs, sedating antihistamines, hypnotics, and tricyclic antidepressants all enhance the central nervous system depressant effects of baclofen — producing additive drowsiness, dizziness, impaired alertness, and respiratory depression. Combined use significantly increases the risk of falls (particularly in the elderly), accidents, and — in overdose — coma and respiratory failure.
Baclofen can enhance the antihypertensive effect of blood pressure medications, including ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, beta-blockers, and diuretics — producing additive hypotension, dizziness on standing, and an increased risk of falls. Dose adjustments may be needed when baclofen is initiated or titrated.
Tricyclic antidepressants (amitriptyline, nortriptyline, dosulepin) can enhance the muscle-relaxant effect of baclofen, producing pronounced muscle weakness. This combination can be problematic in patients who rely on residual muscle tone for posture and ambulation, and dose adjustment may be required.
Levodopa and dopamine agonists used for Parkinson's disease can interact unpredictably with baclofen, with reports of worsening parkinsonian symptoms, confusion, and hallucinations in some patients. Caution is advised, with close clinical monitoring when both drug classes are required.
Baclofen is renally excreted, and concurrent use of other drugs that impair renal function — NSAIDs, certain antibiotics (aminoglycosides), some chemotherapy agents — can raise baclofen plasma levels and increase the risk of toxicity. Dose reduction may be required in patients with declining renal function.
Important Warnings
Baclofen must never be stopped suddenly after extended use. Abrupt discontinuation can precipitate a serious withdrawal syndrome including seizures, hallucinations, confusion, agitation, hyperthermia, severe rebound spasticity, and — rarely — rhabdomyolysis and death. Any planned dose reduction or discontinuation must be tapered gradually over at least 1–2 weeks under clinical supervision.
Baclofen commonly causes drowsiness, dizziness, and impaired alertness, particularly during initiation and dose titration. You must not drive, operate machinery, or perform tasks requiring full alertness until you know how the medication affects you. The effect is significantly worsened by alcohol or sedating medication.
Some patients require their spasticity to maintain upright posture, balance, or limb function. Excessive reduction in tone with baclofen can paradoxically reduce function and mobility, and increase the risk of falls. Dose titration must be individualised and balanced against functional benefit.
Baclofen can lower the seizure threshold and is contraindicated in active epilepsy unless seizures are well controlled and the prescriber has weighed the risks. Patients with a history of seizure disorders should be monitored closely. Sudden withdrawal of baclofen is itself a recognised cause of seizures.
Baclofen is excreted primarily by the kidneys. In patients with significant renal impairment, doses must be reduced substantially and titrated more cautiously to avoid accumulation, severe sedation, confusion, and respiratory depression. The drug should be used with great caution in dialysis patients.
Use during pregnancy is generally avoided unless the benefits clearly outweigh the risks. Baclofen crosses the placenta and may cause neonatal withdrawal syndrome and seizures if used in late pregnancy. Small amounts pass into breast milk; breastfeeding is generally avoided. Specialist advice is essential for women planning pregnancy or breastfeeding.
Use caution in patients with psychotic disorders, schizophrenia, or confusional states, as baclofen has been reported to exacerbate these conditions. Patients with stroke, cerebrovascular disease, severe respiratory disease, or hepatic impairment also require careful dose titration and monitoring.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Baclofen FAQs
Baclofen is an antispastic and skeletal muscle relaxant used to reduce muscle stiffness and spasms caused by neurological conditions such as multiple sclerosis, spinal cord injury or disease, cerebral palsy, stroke, and traumatic brain injury. It works centrally, on nerves in the spinal cord, rather than directly on the muscles themselves.
Baclofen is typically started at a low dose (5 mg three times daily) and gradually increased every few days as tolerated, until symptoms are controlled. The usual maintenance dose is 30–75 mg per day in divided doses, with a maximum of 100 mg per day in most adults. Elderly patients and those with kidney problems are started on lower doses. Always follow the specific dose your clinician has prescribed.
Some reduction in spasm and stiffness may be noticed within a few days of starting baclofen, but the full effect develops gradually as the dose is titrated over 1–2 weeks. Many patients find that physiotherapy and stretching programmes become more effective once baclofen has reduced their tone.
No — never stop baclofen suddenly. Abrupt withdrawal can cause a serious syndrome including rebound spasticity, hallucinations, seizures, confusion, high fever, and — rarely — muscle breakdown and death. If you need to stop baclofen, your clinician will reduce the dose gradually over at least 1–2 weeks. If you have missed several doses, contact your clinician for advice.
Yes — baclofen commonly causes drowsiness, dizziness, and impaired alertness, particularly when starting treatment or after a dose increase. You must not drive, operate machinery, or carry out tasks requiring full alertness until you know how the medication affects you. The effect is worsened by alcohol or other sedating medication.
You should avoid or strictly limit alcohol while taking baclofen. Alcohol significantly increases the drowsiness, dizziness, and slowed reactions that baclofen can already cause, raising the risk of falls and accidents. The combination can also produce dangerous respiratory depression, particularly at higher doses.
Baclofen is generally avoided in pregnancy and breastfeeding unless clearly necessary. If you become pregnant while taking baclofen, do not stop suddenly — contact your specialist for advice on how to manage your treatment safely. Specialist supervision is essential in pregnancy and the early postnatal period to monitor both you and the baby.
If you forget a dose, take it as soon as you remember unless it is nearly time for the next dose — in which case skip the missed dose and continue with your normal schedule. Do not take a double dose to make up for the missed one. If you have missed several consecutive doses, contact your clinician rather than restarting at the full dose, because of the risk of withdrawal symptoms.